Biological
4CMenB
4CMenB is a biological therapy with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_2
1
25%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (50.0%)
Phase 41 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completed
Safety of 4CMenB Exposure During Pregnancy
NCT02640677
completed
Bexsero™and Routine Infant Vaccines: Effect of Coadministration on the Safety of Immunization
NCT02712177
completedphase_4
Investigating the Immune Response to 4CMenB in Infants
NCT02080559
completedphase_2
Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults
NCT00560313
Clinical Trials (4)
Showing 4 of 4 trials
NCT02640677
Safety of 4CMenB Exposure During Pregnancy
NCT02712177
Bexsero™and Routine Infant Vaccines: Effect of Coadministration on the Safety of Immunization
NCT02080559Phase 4
Investigating the Immune Response to 4CMenB in Infants
NCT00560313Phase 2
Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4